Match!
Morten Andersen
University of Copenhagen
Medical prescriptionPopulationAnesthesiaDiabetes mellitusMedicine
221Publications
38H-index
4,686Citations
What is this?
Publications 270
Newest
#1Hadia Hashimi (UCPH: University of Copenhagen)
#2Morten Andersen (UCPH: University of Copenhagen)H-Index: 38
Last. Maurizio Sessa (UCPH: University of Copenhagen)H-Index: 10
view all 3 authors...
OBJECTIVE: This study investigated which comorbidities or comedications increased the probability of receiving quetiapine extended release formulation (quetiapine XR) as an add-on treatment. METHODS: Danish administrative registers were used as data sources. The study period was from January 1, 2011 to July 1, 2017. New users of Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin and Norepinephrine Reuptake Inhibitors (SNRI), Atypical Antidepressants (AAD) and Tricyclic Antidepressants (TC...
Source
OBJECTIVE: The subset distribution and immunophenotype of circulating immune cells ("peripheral blood immune cell profile") may reflect tumor development and response to cancer treatment. In order to use the peripheral blood immune cell profile as biomarker to monitor patients over time, it is crucial to know how immune cell subsets respond to therapeutic interventions. In this study, we investigated the effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile ...
Source
#1Katrine Hass Rubin (University of Southern Denmark)H-Index: 11
#2Søren Møller (University of Southern Denmark)H-Index: 47
Last. Bo Abrahamsen (University of Southern Denmark)H-Index: 45
view all 8 authors...
Abstract Background This observational safety study used national registers to compare the real world cardiovascular and skeletal safety of zoledronic acid (ZA) against oral bisphosphonates (oBP) and untreated population controls. Methods Propensity score matched cohort study in Sweden and Denmark. Results Matched cohort 1 included 8739 ZA users and 25,577 oBP users while matched cohort 2 included 8731 ZA users and 25,924 untreated subjects. In comparison to oBP users, heart failure risk was hig...
Source
#1Diana M. Rydberg (KI: Karolinska Institutet)H-Index: 3
#2Marie Linder (KI: Karolinska Institutet)H-Index: 9
Last. Morten Andersen (KI: Karolinska Institutet)H-Index: 38
view all 4 authors...
PURPOSE: To investigate risk factors for severe bleeding during warfarin treatment, including the influence of sex, age, comorbidity and co-medication on bleeding risk. METHODS: Patients initiating warfarin treatment between 2007 and 2011 were identified in the nationwide Swedish Prescribed Drug Register, and diagnoses of severe bleeding were retrieved from the National Patient Register. Hazard ratios (HR) with 95% confidence intervals (CI) for severe bleeding were estimated using multiple Cox r...
Source
#1Sarah L. Kvorning (AU: Aarhus University)H-Index: 1
#2Marlene Christina Nielsen (Aarhus University Hospital)
Last. Holger Jon Møller (Aarhus University Hospital)H-Index: 38
view all 6 authors...
OBJECTIVES: Extracellular vesicles (EVs) are important for intercellular signalling in cancer. Tumour-associated macrophages, expressing the haemoglobin-haptoglobin and mannose receptors CD163 and CD206, are crucial for cancer progression. We recently identified CD163 on EVs in the circulation as a fraction of total soluble CD163 (sCD163). Here, we investigated the presence of CD163 and CD206-positive EVs (EV-CD163, EV-CD206) in patients with multiple myeloma (MM). METHODS: We enrolled patients ...
1 CitationsSource
#1Laura Pazzagli (KI: Karolinska Institutet)
#2Lena Brandt (KI: Karolinska Institutet)H-Index: 38
Last. Shahram Bahmanyar (KI: Karolinska Institutet)H-Index: 18
view all 7 authors...
Purpose To assess the impact on exposure time and outcome misclassifications, and consequent impact on exposure-outcome associations from treatment episode construction. We investigated the dosage assumptions of 1 unit per day, and 1 DDD per day, versus actual prescribed dosage under different handling of gaps and overlaps of prescriptions.
Source
#1Johan Reutfors (Karolinska University Hospital)H-Index: 14
#2Philip Brenner (Karolinska University Hospital)H-Index: 5
Last. Lena Brandt (Karolinska University Hospital)H-Index: 38
view all 6 authors...
Introduction This post-authorization safety study (PASS) was a commitment to the European Medicines Agency.
Source
#1Lisa C. Holthof (VUmc: VU University Medical Center)H-Index: 2
#2Hilma J. van der Horst (VUmc: VU University Medical Center)H-Index: 1
Last. Tuna MutisH-Index: 39
view all 14 authors...
2 CitationsSource
#1Maurizio Sessa (UCPH: University of Copenhagen)H-Index: 10
#2Daniel Bech Rasmussen (UCPH: University of Copenhagen)
Last. Morten Andersen (UCPH: University of Copenhagen)H-Index: 38
view all 6 authors...
ABSTRACT This study aims to compare the survival and the risk of heart failure, chronic obstructive pulmonary disease, diabetes mellitus, hypoglycemia, and renal failure hospitalizations in geriatric patients that were exposed to carvedilol or metoprolol. Danish administrative healthcare registers were used as data sources. Patients aged ≥ 65 and having heart failure, chronic obstructive pulmonary disease, and diabetes mellitus were followed for 1 year from the date of the first beta-blocker pre...
Source
#1Maurizio Sessa (UCPH: University of Copenhagen)H-Index: 10
#2Annamaria MascoloH-Index: 8
Last. Morten Andersen (UCPH: University of Copenhagen)H-Index: 38
view all 4 authors...
AbstractObjectives: This study aimed to compare the risk of fractures, acute myocardial infarction, atrial fibrillation, and ventricular arrhythmia among Danish citizens aged ≥ 65 which were new us...
Source
12345678910